The nutritional efficiency of nicotinamide iV-oxide and TV'-methylnicotinamide as substitutes for nicotinic acid was investigated using weanling rats fed with a nicotinic acid-free and tryptophan-limited diet (basal diet; negative control), the basal diet containing 0.003% nicotinic acid (positive control), or basal diet containing various amounts of nicotinamide TV-oxide or W-methylnicotinamide. The relative niacin activity of nicotinamide TV-oxideand W-methylnicotinamideto nicotinic acid was about 1/5 and 1/2 on a weight basis, respectively, judged from the following comparisons: body weight gain, food intake, food efficiency ratio, the NADcontents in liver and blood, the total nicotinamide content in liver, and the urinary excretion of nicotinamide and its metabolites such as Arl-methylnicotinamide, N1 -methyl-2-pyridone-5-carboxamide, and TV1-methyl-4-pyridone-3-carboxamide.
Wehave reported that the urinary excretion of nicotinamide and its metabolites such as N^methylnicotinamide (MNA), A^1-methyl-2-pyridone-5-carboxamide (2-Py), and A^-methyl-4-pyridone-3-carboxamide (4-Py) increased significantly when nicotinamide TV-oxide or TV'-methylnicotinamide was injected into mice as well as when nicotinamide was.1} Namely,
we have suggested that a part of nicotinamide TV-oxide and A^-methylnicotinamide are converted into nicotinamide so that these compounds have niacin activity for animals. However, growth-promoting activity and the relative activity of nicotinamideJV-oxide and A^-methylnicotinamide to nicotinic acid have not been measured. Therefore, we investigated these issues using rats. 7V'-Methyl-2-pyridone-5-carboxamide and A^ '-methyl-4-pyridone-3-carboxamide (4-Py) were synthesized from MNAchloride by the methods of Pullman and Colowick2) and Shibata et al., 3) respectively. All other chemicals used were of the highest purity obtainable from commercial sources.
Materials and Methods
Animal experiments. Weanling male rats of the Wistar strain (3 weeks old) were obtained from Clea Japan Inc. The rats were placed in individual metabolic cages (CT-10; Clea Japan) on arrival. In experiment I, the rats were fed ad libitum with a tryptophan-limited and nicotinic acid-free diet (basal diet; negative control), the basal diet containing nicotinamide TV-oxide (0.006, 0.015, 0.021, and 0.03%), or the basal diet containing 0.003% nicotinic acid (positive control) for 31 days. In experiment II, the rats were fed ad libitum with the basal diet (negative control), the basal Obtained from Aldrich Chemical Co., Inc.
Obtained from Sigma Chemical Co.
compositions of the diets used are given in Table I . Twenty-four-hour urine samples (10:00 a.m.-10:00 a.m.) on the last day of the experiment were collected into flasks containing lml of 1m HC1 and stored at -25°C until analyzed.
Blood was taken from the rats' tail vein before they were killed and used immediately for the measurement ofNAD. The rats were killed by decapitation at around 10:00 a.m. on the 32nd day of the experiment, and the livers were removed and immediately used for the measurements of NAD and total nicotinamide.
The room temperature was kept at 22+2°C and the humidity was around 60%. A 12-hr light/dark cycle was maintained. Body weight and food intake were measured daily at around 10:00 a.m. and food and water were renewed daily.
Analyses. The contents of nicotinamide, 2-Py, and 4-Py in urine and the content of liver total nicotinamide were measured by the high-performance liquid chromatographic 
Results
Experiment I (niacin activity of nicotinamide N-oxide) Body weight gain, food intake, and food efficiency ratio (FER). Figure 2 shows growth curves of the rats during the experiment and the final gain in body weights is shown in Table  II . The gain in body weight, food intake, and FER were statistically significantly increased by the addition of 0.006% nicotinamide TV-oxide to the basal diet (negative control) and these values were not different from the group fed with the 0.003% nicotinic acid-supplemented diet (positive control), as shown in Table II . Increasing the supplement of nicotinamide TV-oxide to the basal diet did not give any more body weight gain, food intake, or FER (Table II) . Thus, the relative niacin activity of nicotinamde TV-oxide to nicotinic acid was about 1/2 on a weight basis, judged from the results of body weight gain, food intake, and FER. NADcontents in liver and blood and total nicotinamide content in liver. Liver weight was still lower than those of the group fed with the 0.003% nicotinic acid-supplemented diet (Table  III) . When 0.015% nicotinamide TVoxide was added to the basal diet, these values were almost the same as the group fed with the 0.015% nicotinamide TV-oxide-supplemented diet and the 0.003% nicotinic acid-supplemented diet (Table  III) . Increasing the nicotinamide TV-oxide did not give any more increase ofNADor total nicotinamide. So, the relative niacin activity of nicotinamide TV-oxide to nicotinic acid was about 1/5 judged from the results of liver weight gain, the NAD content in liver and blood, and the total nicotinamide content in liver.
Urinary excretion of nicotinamide and its metabolites. The respective urinary excretion of nicotinamide, MNA,2-Py, and 4-Py was increased with increasing nicotinamide TV-oxide in the basal diet as shown in Table III . The sum of urinary excretion of nicotinamide, MNA,2-Py, and 4-Py was almost the same between the groups fed with the 0.015% nicotinamide TV-oxide-supplemented diet and the 0.003% nicotinic acid-supplemented diet. The urinary excretion of nicotinamide TV-oxide naturally increased with increasing nicotinamide TV-oxide. Thus, the relative niacin activity of nicotinamide TV-oxide to nicotinic acid was about 1/5, judged from the results of urinary excretion of nicotinamide and its metabolites. Body weight gain, food intake, and FER. Figure 3 shows growth curves of the rats during the experiment and the final gain in body weights is shown in Table IV . The gain in body weight, food intake, and FER were statistically significantly increased by the addition of 0.003% TV'-methylnicotinamide to the basal diet, but, these values were still lower than those of the group fed with the 0.003% nicotinic acid-supplmented diet, as shown in Table IV . When 0.006% of A^-methylnicotinamide was added to the basal diet, these values were almost the same with the group fed with the 0.003% nicotinic acid-supplemented diet (Table IV). Increasing the Af'-methylnicotinamide did not give any more body weight gain, food Nicotinic Acid (å ). Each value is for the meanof5 rats.
intake, or FER. Thus, the relative niacin activity of TV'-methylnicotinamide to nicotinic acid was about 1/2, judged from the results of body weight gain, food intake, and FER. NADcontents in liver and blood and total nicotinamide content in liver. The liver weight wasstatistically significantly increased by the supplement of the 0.003% TV'-methylnicotinamide to the basal diet, but, its value was still lower than the group fed with the 0.003% nicotinic acid-supplemented diet, as shown in Table V . When 0.006% TV'-methylnicotinamide was added to the basal diet, the liver weight was almost the same with the group fed with the 0.003% nicotinic acid-supplemented diet. More TV'-methylnicotinamide did not give any more increase in liver weight. The content of NADand total nicotinamide in liver and the conent of NAD in blood was statistically significantly increased by the addition of the 0.003% A^'-methylnicotinamide to the basal diet and these values were increased with increasing TV'-methylnicotinamide up to 20) 0.009% (Table V) . When 0.009% TV'-methylnicotinamide was added to the basal diet, these values were almost the same with the groups fed with the 0.003% nicotinic acid-supplemented diet. Thus, the relative niacin activity of TV'-methylnicotinamide was about 1/3, judged from the results of liver weight gain, the NADcontents in liver and blood and total nicotinamide content in liver.
Urinary excretion of nicotinamide and its metabolites. The respective urinary excretion of nicotinamide, MNA, 2-Py, and 4-Py was increased with increasing TV'-methylnicotinamide to the basal diet, as shown in Table V .
The urinary excretion of TV'-methylnicotinamide naturally increased with increasing TV'-methylnicotinamide.
The sum of urinary excretion of nicotinamide, MNA,2-Py, and 4-Py was about the same between the groups of the 0.006% TV'-methylnicotinamide-supplemented diet and the 0.003% nicotinic acidsupplemented diet. Thus, the relative niacin activity of TV'-methylnicotinamide was about 1/2, judged from the results of the urinary excretion of nicotinamide and its metabolites.
Discussion
These experiments were done to measure the relative niacin activity of nicotinamide TV-oxide and TV'-methylnicotinamide to nicotinic acid in rats. MNA,2-Py, and 4-Py, which are major metabolites ofnicotinamide, do not have niacin activity. The reactions MNA-» nicotinamide, 2-Py ->MNA-> nicotinamide, 4-Py -> MNA -åº nicotinamide do not occur in animals. Nicotinamide TV-oxide is also a metablite of nicotinamide in rodents,8'9) although it is not detected in other kinds of animals.10) In rats, it occupies about 1% of the sum of urinary excretion ofnicotinamide and its metabolites,53 in mice 35%, in guinea pigs 3%, and in hamsters 15%.9\ TV'-Methylnicotinamide has reported to be also an abundant nicotinamide metabolite in humans.1'1* Nicotinamide TV-oxide is known to be reduced to form nicotinamide by xanthine oxidase12) and aldehyde oxidase13) in vitro. In this experiment, the addition of nicotinamide TV-oxide to the niacin-free and tryptophanlimited diet (basal diet; negative control) caused an increase in the body weight gain (Table II) as well as in the NADcontents in liver and blood and in the urinary excretion of nicotinamide and its metabolites (Table III) . These results mean that nicotinamide TV-oxide is converted into nicotinamide in vivo as well as in vitro. The relative niacin activity of nicotinamide TV-oxide to nicotinic acid was around 1/5 in rats from these results (Tables   II and III) . In this connection, Tatsumi and Kanamitsu14'15) reported that nicotinic acid TV-oxide was reduced to nicotinic acid in rats and is also used, although to a very small extent (1/ The enzyme catalyzing the conversion reaction of TV'-methylnicotinamide -> nicotinamide is not known in vitro, however, the reaction was found to occur in vivo since the body weight gain, the NADcontents in liver and blood, the total nicotinamide content in liver, and the urinary excretion of nicotinamide and its metabolites were increased significantly by the addition of TV'-methylnicotinamide to the tryptophan-limited and nicotinic acid-free diet (Tables IV and V) . The relative niacin activity of TV'-methymicotinamide to nicotinic acid was around 1/2 in rats from these results (Tables IV and V) . It is also reported that TV'-methylnicotinamide show vitamin activity for dogs.18)
